Drugs / mRNA-4203
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06946225 | Jul 2025 → Aug 2029 expected | cutaneous melanoma, synovial sarcoma | Immatics US, Inc. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA-4203 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06946225 ↗ |